These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12888711)

  • 1. ALLHAT and ANBP2: what have we learned from recent mega-trials?
    Sander GE; Giles TD
    Am J Geriatr Cardiol; 2003; 12(4):267-71. PubMed ID: 12888711
    [No Abstract]   [Full Text] [Related]  

  • 2. ALLHAT and AFFIRM.
    Liebson PR
    Prev Cardiol; 2003; 6(1):54-60. PubMed ID: 12624564
    [No Abstract]   [Full Text] [Related]  

  • 3. ALLHAT and beyond.
    Alderman MH
    Am J Hypertens; 2003 Jun; 16(6):512-4. PubMed ID: 12799104
    [No Abstract]   [Full Text] [Related]  

  • 4. ALLHAT: a saga of missed opportunities.
    McInnes GT
    J Hum Hypertens; 2003 Jun; 17(6):373-7. PubMed ID: 12764398
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments on the renal aspects of the ALLHAT study.
    Ruilope LM
    J Hypertens; 2003 Feb; 21(2):235-6. PubMed ID: 12569244
    [No Abstract]   [Full Text] [Related]  

  • 6. ALLHAT says diuretics are better; ANBP2 says ACEs are better--can we resolve the differences?
    Vidt DG
    Cleve Clin J Med; 2004 Feb; 71(2):145-50. PubMed ID: 14982197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
    Beevers DG; Lee KW; Lip GY
    J Hum Hypertens; 2003 Jun; 17(6):367-72. PubMed ID: 12764397
    [No Abstract]   [Full Text] [Related]  

  • 8. ALLHAT: a critical assessment.
    Sjöholm A
    Blood Press; 2004; 13(2):75-9. PubMed ID: 15182109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALLHAT: what has it taught us so far?
    Leenen FH
    CMAJ; 2004 Sep; 171(7):719-20. PubMed ID: 15451829
    [No Abstract]   [Full Text] [Related]  

  • 10. Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT.
    Laragh JH; Sealey JE
    Am J Hypertens; 2003 May; 16(5 Pt 1):407-15. PubMed ID: 12745204
    [No Abstract]   [Full Text] [Related]  

  • 11. Results of the ALLHAT trial: is the debate about initial antihypertensive drug therapy over?
    Moser M
    J Clin Hypertens (Greenwich); 2003; 5(1):5-8. PubMed ID: 12556646
    [No Abstract]   [Full Text] [Related]  

  • 12. A specialist in clinical hypertension critiques ALLHAT.
    Meltzer JI
    Am J Hypertens; 2003 May; 16(5 Pt 1):416-20. PubMed ID: 12745205
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ALLHAT report: a case of information and misinformation.
    Weber MA
    J Clin Hypertens (Greenwich); 2003; 5(1):9-13. PubMed ID: 12556647
    [No Abstract]   [Full Text] [Related]  

  • 15. Should ethnicity serve as the basis for clinical trial design? Importance of race/ethnicity in clinical trials: lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Taylor AL; Wright JT
    Circulation; 2005 Dec; 112(23):3654-60; discussion 3666. PubMed ID: 16330707
    [No Abstract]   [Full Text] [Related]  

  • 16. The ALLHAT trial: strengths and limitations.
    Fagard RH
    J Hypertens; 2003 Feb; 21(2):229-32. PubMed ID: 12569242
    [No Abstract]   [Full Text] [Related]  

  • 17. The ALLHAT trial: a verdict or a challenge?
    Zanchetti A; Mancia G
    J Hypertens; 2003 Feb; 21(2):223. PubMed ID: 12569240
    [No Abstract]   [Full Text] [Related]  

  • 18. The ALLHAT and the cardioprotection conferred by diuretics in hypertensive patients: a connection with uric acid?
    Reyes AJ; Leary WP
    Cardiovasc Drugs Ther; 2002 Dec; 16(6):485-7. PubMed ID: 12797357
    [No Abstract]   [Full Text] [Related]  

  • 19. All hats off to ALLHAT: a massive study with clear messages.
    Chalmers J
    J Hypertens; 2003 Feb; 21(2):225-8. PubMed ID: 12569241
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines for antihypertensive treatment: an update after the ALLHAT study.
    Salvetti A; Ghiadoni L
    J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S51-4. PubMed ID: 14684673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.